|
C17ORF80 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.795900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.172000E-01 |
| Normal-vs-Stage2 |
2.245400E-01 |
| Normal-vs-Stage3 |
2.88790000002592E-06 |
| Normal-vs-Stage4 |
1.54397999999611E-05 |
| Stage1-vs-Stage2 |
3.065200E-01 |
| Stage1-vs-Stage3 |
2.40039999988007E-07 |
| Stage1-vs-Stage4 |
1.72272999999779E-05 |
| Stage2-vs-Stage3 |
3.212200E-02 |
| Stage2-vs-Stage4 |
2.198500E-02 |
| Stage3-vs-Stage4 |
8.258200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.395000E-03 |
| Normal-vs-AfricanAmerican |
6.862300E-02 |
| Normal-vs-Asian |
2.745900E-02 |
| Caucasian-vs-AfricanAmerican |
9.718800E-01 |
| Caucasian-vs-Asian |
9.199800E-03 |
| AfricanAmerican-vs-Asian |
1.891990E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.585800E-04 |
| Normal-vs-Female |
1.827560E-01 |
| Male-vs-Female |
2.945700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.835200E-03 |
| Normal-vs-Age(41-60Yrs) |
6.429700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.723700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.012960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.769040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.417600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.988400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.175600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.415600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.816000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.299900E-02 |
| Normal-vs-Grade 2 |
7.233000E-01 |
| Normal-vs-Grade 3 |
1.642140E-04 |
| Normal-vs-Grade 4 |
1.76569999732479E-08 |
| Grade 1-vs-Grade 2 |
6.675900E-02 |
| Grade 1-vs-Grade 3 |
2.810500E-04 |
| Grade 1-vs-Grade 4 |
4.78889999988574E-07 |
| Grade 2-vs-Grade 3 |
9.83580000000206E-05 |
| Grade 2-vs-Grade 4 |
5.82460002451768E-09 |
| Grade 3-vs-Grade 4 |
4.877700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.149600E-01 |
| Normal-vs-ccB subtype |
7.88679999974562E-07 |
| ccA subtype-vs-ccB subtype |
2.65742983174277E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.469800E-02 |
| Normal-vs-N1 |
1.624700E-03 |
| N0-vs-N1 |
1.160360E-01 |
|
|
